CD163 and breast cancer: When studying macrophage subpopulations in BC-tumour-draining LNs using a scRNA-seq approach, Xu et al. (2021) found a polarisation towards M2 subtypes characterised by expression of CD163, CCL18, CCL13, and MRC1 [47].